IMPACT OF ADJUNCT TREATMENT WITH MAITAKE-SX FRACTION ON GLYCEMIC CONTROL

舞茸-SX 组分辅助治疗对血糖控制的影响

• 批准号: 7606866
• 负责人: ALAN SEGAL
• 金额: $ 2.48万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7606866
• 关键词: Blood Glucose; Computer Retrieval of Information on Scientific Projects Database; Diabetes Mellitus; Fasting; Funding; Grant; Institution; Maitake; Non-Insulin-Dependent Diabetes Mellitus; Patients; Purpose; Research; Research Personnel; Resources; Source; Testing; United States National Institutes of Health; glucose tolerance; glycemic control; improved

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the hypothesis that that the product, Maitake-SX fraction, will decrease fasting blood glucose and improve glucose tolerance in patients with type 2 diabetes, without a significant impact on patients without diabetes.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的目的是检验以下假设：Maitake-SX的分数将降低空腹血糖并提高2型糖尿病患者的葡萄糖耐受性，而不会对没有糖尿病的患者产生重大影响。